Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
Erythrodermic psoriasis (EP) is a severe form of psoriasis precipitated by numerous factors, including physical stress, infections, and drugs. The disease represents a therapeutic challenge, and little is known about its response to ustekinumab. Though the efficacy of ustekinumab has been extensivel...
Main Authors: | Rosita Saraceno, Marina Talamonti, Marco Galluzzo, Andrea Chiricozzi, Antonio Costanzo, Sergio Chimenti |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2013-09-01
|
Series: | Case Reports in Dermatology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/348645 |
Similar Items
-
Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01) -
Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab
by: S. Signa, et al.
Published: (2019-07-01) -
Updates on the Treatment of Erythrodermic Psoriasis
by: Lo Y, et al.
Published: (2021-06-01) -
Erythrodermic psoriasis treated with apremilast
by: John Arcilla, et al.
Published: (2016-09-01) -
Erythrodermic psoriasis: pathophysiology and current treatment perspectives
by: Singh RK, et al.
Published: (2016-07-01)